未登录

C

Christina Addison

ottawa hospital research institute

H指数:39

被引数:6,899

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Metabolic Vulnerabilities as a Therapeutic Target in Breast Cancer

代谢脆弱性作为乳腺癌的治疗靶点

Current Oncology

IF3.4

2026-02-230

OAAI

Doxorubicin enhances adipogenesis in an FGF2-dependent manner and induces a tumour-promoting secretory phenotype

多柔比星以FGF2依赖的方式增强脂肪生成，并诱导肿瘤促进性分泌表型。

Journal of Bone Oncology

IF3.5

2026-02-210

OAAI

It's a Trap! Aldolase-Prescribed C4 Deoxyradiofluorination Affords Intracellular Trapping and the Tracing of Fructose Metabolism by PET

JOURNAL OF NUCLEAR MEDICINE

IF9.1

2024-01-251

OA

Perk-dependent translational regulation promotes tumor cell adaptation and angiogenesis in response to hypoxic stress

MOLECULAR AND CELLULAR BIOLOGY

IF2.7

2023-03-27287

OAAI

Focal adhesion kinase inhibitors prevent osteoblast mineralization in part due to suppression of Akt-mediated stabilization of osterix

JOURNAL OF BONE ONCOLOGY

IF3.5

2022-06-015

OAAI

VIVA1: a more invasive subclone of MDA-MB-134VI invasive lobular carcinoma cells with increased metastatic potential in xenograft models

BRITISH JOURNAL OF CANCER

IF6.8

2022-03-220

OA

Mapping vitamin B6 metabolism by hydrazoCEST magnetic resonance imaging

CHEMICAL COMMUNICATIONS

IF4.2

2021-01-016

PRE

The plasma peptides of breast versus ovarian cancer

CLINICAL PROTEOMICS

IF3.3

2019-12-2320

OAAI

Co-inhibition of mTORC1, HDAC and ESR1a retards the growth of triple-negative breast cancer and suppresses cancer stem cells

CELL DEATH & DISEASE

IF9.6

2018-07-2635

OAAI

Effects on bone resorption markers of continuing pamidronate or switching to zoledronic acid in patients with high risk bone metastases from breast cancer

JOURNAL OF BONE ONCOLOGY

IF3.5

2018-03-016

OAAI

Dual inhibition of Wnt and Yes-associated protein signaling retards the growth of triple-negative breast cancer in both mesenchymal and epithelial states

Wnt和Yes相关蛋白信号传导的双重抑制可抑制间充质和上皮状态下三阴性乳腺癌的生长

MOLECULAR ONCOLOGY

IF4.5

2018-02-2164

OAAI

Both bulk and cancer stem cell subpopulations in triple-negative breast cancer are susceptible to Wnt, HDAC, and ERα coinhibition

IF3

2016-12-0931

OAAI

Strategies for obtaining bone biopsy specimens from breast cancer patients - Past experience and future directions

JOURNAL OF BONE ONCOLOGY

IF3.5

2016-11-011

OAAI

A phase 2 trial exploring the clinical and correlative effects of combining doxycycline with bone-targeted therapy in patients with metastatic breast cancer

JOURNAL OF BONE ONCOLOGY

IF3.5

2016-11-0111

OAAI

Estrogen, progesterone, and HER2/neu receptor discordance between primary and metastatic breast tumours-a review

原发性和转移性乳腺肿瘤之间的雌激素，孕激素和HER2/neu受体不一致-综述

CANCER AND METASTASIS REVIEWS

IF8.7

2016-07-1270

PREAI

Future directions for bone metastasis research - highlights from the 2015 bone and the Oncologist new updates conference (BONUS)

JOURNAL OF BONE ONCOLOGY

IF3.5

2016-06-0113

OAAI

Angiotensin-Converting Enzyme and Aldosterone Serum Levels as Prognostic and Predictive Biomarkers for Cediranib in NCIC Clinical Trials Group Study BR.24

CLINICAL LUNG CANCER

IF3.3

2015-11-016

PRE

Perivascular M2 Macrophages Stimulate Tumor Relapse after Chemotherapy

血管周围M2巨噬细胞刺激化疗后肿瘤复发

CANCER RESEARCH

IF16.6

2015-08-31422

OAAI

Correlation of baseline biomarkers with clinical outcomes and response to fulvestrant with vandetanib or placebo in patients with bone predominant metastatic breast cancer: An OCOG ZAMBONEY sub-study

JOURNAL OF BONE ONCOLOGY

IF3.5

2015-06-019

OAAI

Oncologist treatment choices in patients with early stage invasive lobular breast carcinoma - a survey

CANCER RESEARCH

IF16.6

2015-05-010

PRE